Header Logo

Connection

Catherine Schaefer to Pharmacogenomic Testing

This is a "connection" page, showing publications Catherine Schaefer has written about Pharmacogenomic Testing.
Connection Strength

0.355
  1. Associations of CYP2C9 and CYP2C19 Pharmacogenetic Variation with Phenytoin-Induced Cutaneous Adverse Drug Reactions. Clin Transl Sci. 2020 09; 13(5):1004-1009.
    View in: PubMed
    Score: 0.181
  2. Assessing the clinical impact of CYP2C9 pharmacogenetic variation on phenytoin prescribing practice and patient response in an integrated health system. Pharmacogenet Genomics. 2019 10; 29(8):192-199.
    View in: PubMed
    Score: 0.174

© 2024 Kaiser Permanente